Zobrazeno 1 - 10
of 19
pro vyhledávání: '"P R Taub"'
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Diabetic cardiomyopathy (DbCM) is characterized by asymptomatic stage B heart failure (SBHF) caused by diabetes-related metabolic alterations. DbCM is associated with an increased risk of progression to overt heart failure (HF). T
Externí odkaz:
https://doaj.org/article/4fd1b21922974d87b9382580c8a622e9
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100666- (2024)
Purpose of Review: Cardiovascular disease is a leading cause of death worldwide. Dyslipidemia is a critical modifiable risk factor for the prevention of cardiovascular disease. Dyslipidemia affects a large population of women and is especially pervas
Externí odkaz:
https://doaj.org/article/253c6afb92cc48339ade20295aa4cd68
Autor:
Beatrice A. Golomb, Roel Sanchez Baez, Jan M. Schilling, Mehul Dhanani, McKenzie J. Fannon, Brinton K. Berg, Bruce J. Miller, Pam R. Taub, Hemal H. Patel
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Gulf War illness (GWI) is an important exemplar of environmentally-triggered chronic multisymptom illness, and a potential model for accelerated aging. Inflammation is the main hypothesized mechanism for GWI, with mitochondrial impairment al
Externí odkaz:
https://doaj.org/article/c96f6dc30f414d43a2648e2e3b97e337
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Lowering low‐density lipoprotein cholesterol (LDL‐C) is a cornerstone of reducing risk for atherosclerotic cardiovascular disease. Despite the approval of nonstatin therapies for LDL‐C lowering over the past 2 decades, these medications are und
Externí odkaz:
https://doaj.org/article/835ec1596c954dc9a85b1b1de043360b
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100541- (2023)
Therapeutic Area: ASCVD/CVD in Special Populations Background: Prior studies demonstrate an association between statins and reduction in mortality and incidence of coronary allograft vasculopathy (CAV) following heart transplant, and while lipid lowe
Externí odkaz:
https://doaj.org/article/cb8baaf375534ec3bff81db542c9493b
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100567- (2023)
Therapeutic Area: Pharmacologic Therapy Background: Real-world data examining inclisiran use in US clinical practice are limited. We report a one-year experience with inclisiran in an academic lipid clinic. Methods: Retrospective chart review of pati
Externí odkaz:
https://doaj.org/article/e35a57ef5d5b4a72bc378dc22152983f
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100511- (2023)
High density lipoprotein cholesterol (HDL-C) is a known contributor to atherosclerotic cardiovascular disease (ASCVD) risk when HDL-C 90 mg/dL and >70 mg/dL in women and men, respectively. The ability for the HDL particle to effectively transport cho
Externí odkaz:
https://doaj.org/article/49a52b36fbc5411eab31ffce3dd6a688
Publikováno v:
American Journal of Preventive Cardiology, Vol 13, Iss , Pp 100473- (2023)
Background: We sought to determine whether management of LDL-C following invasive angiography and assessment by fractional flow reserve (FFR) differs between those with obstructive vs non-obstructive CAD. Methods: Retrospective study of 721 patients
Externí odkaz:
https://doaj.org/article/c25206ce90204c249d9437e359c170dd
Autor:
Abby C. Lee, Wei Tse Li, Lauren Apostol, Jiayan Ma, Pam R. Taub, Eric Y. Chang, Mahadevan Rajasekaran, Weg M. Ongkeko
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 3755-3764 (2021)
Background: COVID-19 has infected over 35 million people worldwide and led to over 1 million deaths. Several risk factors that increase COVID-19 severity have emerged, including age and a history of cardiovascular disease, hypertension, or kidney dis
Externí odkaz:
https://doaj.org/article/0f9870cf2c20428ab34e097fc7f56113
Autor:
Satchidananda Panda, Emily N C Manoogian, Adena Zadourian, Hannah C Lo, Nikko R Gutierrez, Azarin Shoghi, Ashley Rosander, Aryana Pazargadi, Xinran Wang, Jason G Fleischer, Shahrokh Golshan, Pam R Taub
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Introduction Career firefighters experience chronic circadian rhythm disruption, increasing their risk of cardiometabolic disease. The recent discovery that eating patterns regulate circadian rhythmicity in metabolic organs has raised the hypothesis
Externí odkaz:
https://doaj.org/article/19cb7caaac844fb1b056d2782041539a